Drug intelligence / Profile preview

ketorolac

Development stage
Approved
Lead developer
Roche
Modality
Small Molecules
Administration
Oral, Intravenous, Intramuscular, Intranasal, Ophthalmic
01

Overview

Ketorolac is a potent, short-term nonsteroidal anti-inflammatory drug (NSAID) used primarily for the management of moderate to severe acute pain, often as an alternative or adjunct to opioid analgesics. It is a non-selective cyclooxygenase (COX) inhibitor that reduces prostaglandin synthesis, resulting in analgesic, anti-inflammatory, and antipyretic effects. Ketorolac is available in several formulations including oral tablets, intramuscular and intravenous injections, nasal spray, and ophthalmic solutions. Its onset of action is rapid (within 30–60 minutes), with peak effect at 1–2 hours and duration up to 6–8 hours. The recommended treatment duration does not exceed five days due to risk of serious adverse effects such as gastrointestinal bleeding and renal impairment[1][2][4][5].

Brand names
ToradolAcularSprixBiorolac
Other names
ketorolac tromethamine酮咯酸氨丁三醇克多罗多克
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on ketorolac.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ketorolac.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call